JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

McKesson Corp

Затворен

СекторЗдравеопазване

835.34 0.87

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

824.3

Максимум

835.92

Ключови измерители

By Trading Economics

Приходи

40M

1.3B

Продажби

3B

106B

P/E

Средно за сектора

24.813

60.328

Дивидентна доходност

0.35

Марж на печалбата

1.177

Служители

43,000

EBITDA

374M

1.8B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+18.17% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.35%

2.24%

Следващи печалби

7.05.2026 г.

Следваща дата на дивидент

1.07.2026 г.

Следваща дата на екс-дивидент

1.06.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

736M

106B

Предишно отваряне

834.47

Предишно затваряне

835.34

Настроения в новините

By Acuity

39%

61%

144 / 348 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

McKesson Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.04.2026 г., 00:00 ч. UTC

Печалби

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24.04.2026 г., 00:00 ч. UTC

Печалби

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23.04.2026 г., 23:47 ч. UTC

Пазарно говорене

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23.04.2026 г., 23:43 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

23.04.2026 г., 23:43 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

23.04.2026 г., 23:43 ч. UTC

Пазарно говорене

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23.04.2026 г., 23:13 ч. UTC

Придобивния, сливания и поглъщания

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23.04.2026 г., 22:33 ч. UTC

Печалби

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23.04.2026 г., 22:17 ч. UTC

Печалби

PLS Executed Offtake Agreement With Ronbay

23.04.2026 г., 22:17 ч. UTC

Печалби

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23.04.2026 г., 22:16 ч. UTC

Печалби

PLS Commences Commissioning of Midstream Demonstration Plant

23.04.2026 г., 22:15 ч. UTC

Печалби

PLS Group Reaffirms FY26 Guidance for All Metrics

23.04.2026 г., 22:14 ч. UTC

Печалби

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23.04.2026 г., 22:14 ч. UTC

Печалби

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23.04.2026 г., 22:13 ч. UTC

Печалби

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23.04.2026 г., 22:12 ч. UTC

Печалби

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23.04.2026 г., 22:12 ч. UTC

Печалби

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23.04.2026 г., 22:11 ч. UTC

Печалби

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23.04.2026 г., 22:10 ч. UTC

Печалби

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23.04.2026 г., 22:09 ч. UTC

Печалби

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23.04.2026 г., 22:08 ч. UTC

Печалби

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23.04.2026 г., 22:04 ч. UTC

Печалби

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23.04.2026 г., 21:56 ч. UTC

Пазарно говорене
Печалби

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23.04.2026 г., 21:48 ч. UTC

Придобивния, сливания и поглъщания

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23.04.2026 г., 21:27 ч. UTC

Печалби

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23.04.2026 г., 21:25 ч. UTC

Печалби

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23.04.2026 г., 21:24 ч. UTC

Печалби

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23.04.2026 г., 21:24 ч. UTC

Печалби

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23.04.2026 г., 21:21 ч. UTC

Печалби

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23.04.2026 г., 21:21 ч. UTC

Печалби

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Сравнение с други в отрасъла

Ценова промяна

McKesson Corp Прогноза

Ценова цел

By TipRanks

18.17% нагоре

12-месечна прогноза

Среден 979.89 USD  18.17%

Висок 1,107 USD

Нисък 885 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за McKesson Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

11 ratings

9

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

681.92 / 707.28Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

No Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

144 / 348 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat